The MDSC phenotype varies by differentiation status and function in response to the environmental conditions of different cancers, and the MDSC phenotype has been defined as the HLA-DR−CD33+CD11b+ cell population, including PMN- and Mo-MDSCs, in many human cancers, including multiple myeloma [12, 27]. This evidence concerns the gene ITGAM and plasma cell myeloma.